American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast. Sales of vaccines against ...
Clinical-stage biotechnology company Vaxxas has appointed three global vaccine experts as advisors as it progresses its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback